Microglia-specific targeting by novel capsid-modified AAV6 vectors
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Recombinant adeno-associated viruses (rAAV) have been widely used in gene therapy applications for central nervous system diseases. Though rAAV can efficiently target neurons and astrocytes in mouse brains, microglia, the immune cells of the brain, are refractile to rAAV. To identify AAV capsids with microglia-specific transduction properties, we initially screened the most commonly used serotypes, AAV1-9 and rh10, on primary mouse microglia cultures. While these capsids were not permissive, we then tested the microglial targeting properties of a newly characterized set of modified rAAV6 capsid variants with high tropism for monocytes. Indeed, these newly characterized rAAV6 capsid variants, specially a triply mutated Y731F/Y705F/T492V form, carrying a self-complementary genome and microglia-specific promoters (F4/80 or CD68) could efficiently and selectively transduce microglia in vitro. Delivery of these constructs in mice brains resulted in microglia-specific expression of green fluorescent protein, albeit at modest levels. We further show that CD68 promoter-driven expression of the inflammatory cytokine, interleukin-6, using this capsid variant leads to increased astrogliosis in the brains of wild-type mice. Our study describes the first instance of AAV-targeted microglial gene expression leading to functional modulation of the innate immune system in mice brains. This provides the rationale for utilizing these unique capsid/promoter combinations for microglia-specific gene targeting for modeling or functional studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Turnover of resident microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., & Gordon, S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90500-2 · Cited by 709
Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Weigel-Van Aken, K. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802866105 · Cited by 558
Self-citationSelf-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., & Samulski, R. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.72 · Cited by 501
The origin and cell lineage of microglia: new concepts
Chan, W. Y., Kohsaka, S., & Rezaie, P. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.11.002 · Cited by 400
Research works printed but not linked: 28
- Lentz, 2012, Viral vectors for gene delivery to the central nervous system, Neurobiol Dis, 48, 179, 10.1016/j.nbd.2011.09.014 · DOI · Paper page
- Murlidharan, 2014, Biology of adeno-associated viral vectors in the central nervous system, Front Mol Neurosci, 7, 76, 10.3389/fnmol.2014.00076 · DOI · Paper page
- Grimm, 2015, E pluribus unum: 50 years of research, millions of viruses, and one goal-tailored acceleration of AAV evolution, Mol Ther, 23, 1819, 10.1038/mt.2015.173 · DOI · Paper page
- Chakrabarty, 2013, Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain, PLoS One, 8, e67680, 10.1371/journal.pone.0067680 · DOI · Paper page
- Ayers, 2015, Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice, Mol Ther, 23, 53, 10.1038/mt.2014.180 · DOI · Paper page
- Weinberg, 2013, Adeno-associated virus (AAV) gene therapy for neurological disease, Neuropharmacology, 69, 82, 10.1016/j.neuropharm.2012.03.004 · DOI · Paper page
- Pandya, 2014, Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy, Immunol Cell Biol, 92, 116, 10.1038/icb.2013.74 · DOI · Paper page
- Aslanidi, 2012, High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors, Vaccine, 30, 3908, 10.1016/j.vaccine.2012.03.079 · DOI · Paper page
- Zhong, 2008, Single-polarity recombinant adeno-associated virus 2 vector-mediated transgene expression in vitro and in vivo: mechanism of transduction, Mol Ther, 16, 290, 10.1038/sj.mt.6300376 · DOI · Paper page
- Clarke, 1998, Myeloid-specific gene expression, J Leukoc Biol, 63, 153, 10.1002/jlb.63.2.153 · DOI
- Asokan, 2012, The AAV vector toolkit: poised at the clinical crossroads, Mol Ther, 20, 699, 10.1038/mt.2011.287 · DOI · Paper page
- Cucchiarini, 2003, Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors, Gene Ther, 10, 657, 10.1038/sj.gt.3301925 · DOI
- Bartlett, 1998, Selective and rapid uptake of adeno-associated virus type 2 in brain, Hum Gene Ther, 9, 1181, 10.1089/hum.1998.9.8-1181 · DOI · Paper page
- Pfrieger, 2012, Genetic approaches to study glial cells in the rodent brain, Glia, 60, 681, 10.1002/glia.22283 · DOI · Paper page
- Balcaitis, 2005, Lentiviral transduction of microglial cells, Glia, 50, 48, 10.1002/glia.20146 · DOI · Paper page
- Martino, 2013, Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells, Blood, 121, 2224, 10.1182/blood-2012-10-460733 · DOI · Paper page
- Jayandharan, 2011, Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy, Proc Natl Acad Sci USA, 108, 3743, 10.1073/pnas.1012753108 · DOI · Paper page
- Aslanidi, 2013, Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?, PLoS One, 8, e59142, 10.1371/journal.pone.0059142 · DOI · Paper page
- Martino, 2009, Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity, PLoS One, 4, e6376, 10.1371/journal.pone.0006376 · DOI · Paper page
- LoDuca, 2009, Hepatic gene transfer as a means of tolerance induction to transgene products, Curr Gene Ther, 9, 104, 10.2174/156652309787909490 · DOI · Paper page
- Horowitz, 2012, Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection, ACS Chem Biol, 7, 1059, 10.1021/cb3000265 · DOI
- Li, 2010, High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy, Hum Gene Ther, 21, 1527, 10.1089/hum.2010.005 · DOI · Paper page
- Tydlacka, 2008, Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons, J Neurosci, 28, 13285, 10.1523/JNEUROSCI.4393-08.2008 · DOI · Paper page
- Niwa, 1991, Efficient selection for high-expression transfectants with a novel eukaryotic vector, Gene, 108, 193, 10.1016/0378-1119(91)90434-D · DOI · Paper page
- Zhong, 2004, Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo, Mol Ther, 10, 950, 10.1016/j.ymthe.2004.07.018 · DOI · Paper page
- Chen, 2011, Cellular fusion for gene delivery to SCA1 affected Purkinje neurons, Mol Cell Neurosci, 47, 61, 10.1016/j.mcn.2011.03.003 · DOI
- Zolotukhin, 1999, Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther, 6, 973, 10.1038/sj.gt.3300938 · DOI · Paper page
- Wang, 2012, Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation, Hum Gene Ther Methods, 23, 225, 10.1089/hgtb.2012.090 · DOI · Paper page
Cited by
Zhong, L., Xu, Y., Zhuo, R., Wang, T., Wang, K., Huang, R., Wang, D., Gao, Y., Zhu, Y., Sheng, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09118-9 · Cited by 371
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 369
When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
Roesch, S., Rapp, C., Dettling, S., & Herold-Mende, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020436 · Cited by 293
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 282
AAV cis -regulatory sequences are correlated with ocular toxicity
Xiong, W., Wu, D. M., Xue, Y., Wang, S. K., Chung, M. J., Ji, X., Rana, P., Zhao, S. R., Mai, S., & Cepko, C. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821000116 · Cited by 249
Directed evolution of adeno-associated virus for efficient gene delivery to microglia
Lin, R., Zhou, Y., Yan, T., Wang, R., Li, H., Wu, Z., Zhang, X., Zhou, X., Zhao, F., Zhang, L., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01547-7 · Cited by 171
“Viral transduction of microglia (and macrophages in general) also faces the potential issue of inducing immune activation 26,31 .”
Gene Therapy Tools for Brain Diseases
Ingusci, S., Verlengia, G., Soukupova, M., Zucchini, S., & Simonato, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00724 · Cited by 158
Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges
Maes, M. E., Colombo, G., Schulz, R., & Siegert, S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134310 · Cited by 145
Perez, B. A., Shutterly, A., Chan, Y. K., Byrne, B. J., & Corti, M. (2020) · Brain Sciences · doi:10.3390/brainsci10020119 · Cited by 112
Nieuwenhuis, B., Haenzi, B., Hilton, S., Carnicer-Lombarte, A., Hobo, B., Verhaagen, J., & Fawcett, J. W. (2021) · Gene Therapy · doi:10.1038/s41434-020-0169-1 · Cited by 114
CD11c(+) microglia promote white matter repair after ischemic stroke
Jia, J., Zheng, L., Ye, L., Chen, J., Shu, S., Xu, S., Bao, X., Xia, S., Liu, R., Xu, Y., et al. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05689-0 · Cited by 100
Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy
Koller, E. J., Gonzalez De La Cruz, E., Machula, T., Ibanez, K. R., Lin, W.-L., Williams, T., Riffe, C. J., Ryu, D., Strang, K. H., Liu, X., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz151 · Cited by 63
Self-citationOkada, Y., Hosoi, N., Matsuzaki, Y., Fukai, Y., Hiraga, A., Nakai, J., Nitta, K., Shinohara, Y., Konno, A., & Hirai, H. (2022) · Communications Biology · doi:10.1038/s42003-022-04200-3 · Cited by 58
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Chandler, L. C., McClements, M. E., Yusuf, I. H., Martinez-Fernandez de la Camara, C., MacLaren, R. E., & Xue, K. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.011 · Cited by 43
“However, it has been previously suggested that microglia are difficult to transduce, with one group detecting no transgene expression by immunohistochemistry following transduction of primary murine microglia in vitro with serotypes AAV1–9.(46) A recent in vivo study also demonstrated that, after subretinal AAV delive…”
BackgroundInfluentialIn Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH
Wang, S. K., Lapan, S. W., Hong, C. M., Krause, T. B., & Cepko, C. L. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.10.003 · Cited by 36
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Dong, Y., Jain, R. W., Lozinski, B. M., D’Mello, C., Visser, F., Ghorbani, S., Zandee, S., Brown, D. I., Prat, A., Xue, M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00205-z · Cited by 32
Zhou, L., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03232-2 · Cited by 26
“The Y731F/Y705F/T492V triple-mutant (TM) AAV6 capsid (rAAV6TM), engineered with mutations affecting various surface-exposed serine and tyrosine residues, initially demonstrated efficacy in transducing primary microglia cultures and mixed neuroglial cultures from mouse [36, 47].”
BackgroundResultInfluentialSimple and highly specific targeting of resident microglia with adeno‐associated virus
Serrano, C., Cananzi, S., Shen, T., Wang, L.-L., & Zhang, C.-L. (2024) · iScience · doi:10.1016/j.isci.2024.110706 · Cited by 23
AAV vectors for specific and efficient gene expression in microglia
Aoki, R., Konno, A., Hosoi, N., Kawabata, H., & Hirai, H. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101116 · Cited by 12
Microglia targeting by adeno-associated viral vectors
Stamataki, M., Rissiek, B., Magnus, T., & Körbelin, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425892 · Cited by 12
Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease
Kim, B., Wang, S. S., Kim, J. R., & Kim, J. (2026) · BioEssays · doi:10.1002/bies.70186
Metadata
- Authors
- Rosario, A. M., Cruz, P. E., Ceballos-Diaz, C., Strickland, M. R., Siemienski, Z., Pardo, M., Schob, K.-L., Li, A., Aslanidi, G. V., Srivastava, A., Golde, T. E., & Chakrabarty, P.
- Venue
- Molecular Therapy - Methods & Clinical Development
- Publisher
- Elsevier BV
- Published
- 2016
- Volume
- 3
- Pages
- 16026
- ISSN
- 2329-0501 (ISSN-L)
- OpenAlex
- W2336296004
- Cited by
- 118
- References
- 15
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 360 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.